NASDAQ:BOWN - Nasdaq - KYG127291105 - Common Stock - Currency: USD
Bowen Acquisition (BOWN) has entered into a definitive merger pact with Shenzhen Qianzhi BioTechnology Co., Ltd, a Chinese-based biotech firm specializing in ozonated health and wellness..
New York, NY, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Bowen Acquisition Corp (NASDAQ: BOWN) (“BOWN”), a special purpose acquisition company, announced the...
NEW YORK, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Bowen Acquisition Corp (NASDAQ: BOWNU) (the “Company”) announced today that, commencing on or about August...
NEW YORK, July 31, 2023 (GLOBE NEWSWIRE) -- Bowen Acquisition Corp (the “Company”) announced today that it closed the sale of an additional 900,000 units...
NEW YORK, July 17, 2023 (GLOBE NEWSWIRE) -- Bowen Acquisition Corp (the “Company”) announced today that it closed its initial public offering of...
NEW YORK, July 11, 2023 (GLOBE NEWSWIRE) -- Bowen Acquisition Corp (the “Company”) announced today that it priced its initial public offering of...